Exosome-mediated Repair of Intervertebral Disc Degeneration: The Potential Role of miRNAs


Cite item

Full Text

Abstract

Intervertebral disc degeneration (IVDD) is a serious condition that manifests as low back pain, intervertebral disc protrusion, and spinal canal stenosis. At present, the main treatment methods for IVDD are surgical interventions such as discectomy, total disc replacement, and spinal fusion. However, these interventions have shown limitations, such as recurrent lumbar disc herniation after discectomy, lesions in adjacent segments, and failure of fixation. To overcome these shortcomings, researchers have been exploring stem cell transplantation therapy, such as mesenchymal stem cell (MSC) transplantation, but the treatment results are still controversial. Therefore, researchers are in search of new methods that are more efficient and have better outcomes. The exosomes from stem cells contain a variety of bioactive molecules that mediate cell interactions, and these components have been investigated for their potential therapeutic role in the repair of various tissue injuries. Recent studies have shown that MSC-derived miRNAs in exosomes and vesicles have therapeutic effects on nucleus pulposus cells, annulus fibrosus, and cartilage endplate. miRNAs play a role in many cell activities, such as cell proliferation, apoptosis, and cytokine release, by acting on mRNA translation, and they may have immense therapeutic potential, especially when combined with stem cell therapy. This article reviews the current status of research on intervertebral disc repair, especially with regard to the latest research findings on the molecular biological mechanisms of miRNAs in MSC-derived exosomes in intervertebral disc repair.

About the authors

Han-Shi Wang

Department of Orthopaedic, The Second Affiliated Hospital of Fujian Medical University

Email: info@benthamscience.net

Shu Lin

Centre of Neurological and Metabolic Research,, The Second Affiliated Hospital of Fujian Medical University,

Author for correspondence.
Email: info@benthamscience.net

Hai-Ming Yu

Department of Orthopaedic, The Second Affiliated Hospital of Fujian Medical University

Author for correspondence.
Email: info@benthamscience.net

References

  1. Cheung KMC, Karppinen J, Chan D, et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine 2009; 34(9): 934-40. doi: 10.1097/BRS.0b013e3181a01b3f PMID: 19532001
  2. Jackson T, Thomas S, Stabile V, Han X, Shotwell M, McQueen K. Prevalence of chronic pain in low-income and middle-income countries: A systematic review and meta-analysis. Lancet 2015; 385(S2): S10. doi: 10.1016/S0140-6736(15)60805-4 PMID: 26313056
  3. Buchbinder R, van Tulder M, Öberg B, et al. Low back pain: A call for action. Lancet 2018; 391(10137): 2384-8. doi: 10.1016/S0140-6736(18)30488-4 PMID: 29573871
  4. Phillips FM, Slosar PJ, Youssef JA, Andersson G, Papatheofanis F. Lumbar spine fusion for chronic low back pain due to degenerative disc disease: A systematic review. Spine 2013; 38(7): E409-22. doi: 10.1097/BRS.0b013e3182877f11 PMID: 23334400
  5. Iorio-Morin C, Fisher CG, Abraham E, et al. Low-back pain after lumbar discectomy for disc herniation: What can you tell your patient? J Neurosurg Spine 2021; 35(6): 715-21. doi: 10.3171/2021.2.SPINE201625 PMID: 34450579
  6. Shipton EA. Physical therapy approaches in the treatment of low back pain. Pain Ther 2018; 7(2): 127-37. doi: 10.1007/s40122-018-0105-x PMID: 30229473
  7. Hooten WM, Cohen SP. Evaluation and treatment of low back pain. Mayo Clin Proc 2015; 90(12): 1699-718. doi: 10.1016/j.mayocp.2015.10.009 PMID: 26653300
  8. Widjaja G, Jalil AT, Budi HS, et al. Mesenchymal stromal/stem cells and their exosomes application in the treatment of intervertebral disc disease: A promising frontier. Int Immunopharmacol 2022; 105: 108537. doi: 10.1016/j.intimp.2022.108537 PMID: 35101851
  9. He XY, Yu HM, Lin S, Li YZ. Advances in the application of mesenchymal stem cells, exosomes, biomimetic materials, and 3D printing in osteoporosis treatment. Cell Mol Biol Lett 2021; 26(1): 47. doi: 10.1186/s11658-021-00291-8 PMID: 34775969
  10. Masuda K, An HS. Growth factors and the intervertebral disc. Spine J 2004; 4(6)(S6): S330-40. doi: 10.1016/j.spinee.2004.07.028 PMID: 15541686
  11. Sampara P, Banala RR, Vemuri SK, Av GR, Gpv S. Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: A review. Gene Ther 2018; 25(2): 67-82. doi: 10.1038/s41434-018-0004-0 PMID: 29567950
  12. Vadalà G, Russo F, Ambrosio L, Loppini M, Denaro V. Stem cells sources for intervertebral disc regeneration. World J Stem Cells 2016; 8(5): 185-201. doi: 10.4252/wjsc.v8.i5.185 PMID: 27247704
  13. Krut Z, Pelled G, Gazit D, Gazit Z. Stem cells and exosomes: New therapies for intervertebral disc degeneration. Cells 2021; 10(9): 2241. doi: 10.3390/cells10092241 PMID: 34571890
  14. Herger N, Bermudez-Lekerika P, Farshad M, et al. Should degenerated intervertebral discs of patients with modic type 1 changes be treated with mesenchymal stem cells? Int J Mol Sci 2022; 23(5): 2721. doi: 10.3390/ijms23052721 PMID: 35269863
  15. Ha DH, Kim H, Lee J, et al. Mesenchymal stem/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration. Cells 2020; 9(5): 1157. doi: 10.3390/cells9051157 PMID: 32392899
  16. Hu ZL, Li HY, Chang X, et al. Exosomes derived from stem cells as an emerging therapeutic strategy for intervertebral disc degeneration. World J Stem Cells 2020; 12(8): 803-13. doi: 10.4252/wjsc.v12.i8.803 PMID: 32952860
  17. Fearing BV, Hernandez PA, Setton LA, Chahine NO. Mechanotransduction and cell biomechanics of the intervertebral disc. JOR Spine 2018; 1(3): e1026. doi: 10.1002/jsp2.1026 PMID: 30569032
  18. Molladavoodi S, McMorran J, Gregory D. Mechanobiology of annulus fibrosus and nucleus pulposus cells in intervertebral discs. Cell Tissue Res 2020; 379(3): 429-44. doi: 10.1007/s00441-019-03136-1 PMID: 31844969
  19. Roberts S, Evans H, Trivedi J, Menage J. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 2006; 88 (Suppl. 2): 10-4. PMID: 16595436
  20. Sun Y, Lyu M, Lu Q, Cheung K, Leung V. Current perspectives on nucleus pulposus fibrosis in disc degeneration and repair. Int J Mol Sci 2022; 23(12): 6612. doi: 10.3390/ijms23126612 PMID: 35743056
  21. Lawan A, Crites VJ, Battié MC. The association between vertebral endplate structural defects and back pain: A systematic review and meta-analysis. Eur Spine J 2021; 30(9): 2531-48. doi: 10.1007/s00586-021-06865-6 PMID: 34021785
  22. Moore RJ. The vertebral endplate: Disc degeneration, disc regeneration. Eur Spine J 2006; 15(S3): S333-7. doi: 10.1007/s00586-006-0170-4
  23. Vergroesen PPA, Kingma I, Emanuel KS, et al. Mechanics and biology in intervertebral disc degeneration: A vicious circle. Osteoarthr Cartil 2015; 23(7): 1057-70. doi: 10.1016/j.joca.2015.03.028 PMID: 25827971
  24. Urban JPG, Smith S, Fairbank JCT. Nutrition of the intervertebral disc. Spine 2004; 29(23): 2700-9. doi: 10.1097/01.brs.0000146499.97948.52 PMID: 15564919
  25. Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nat Rev Rheumatol 2014; 10(1): 44-56. doi: 10.1038/nrrheum.2013.160 PMID: 24166242
  26. Zhang J, Li Z, Chen F, et al. TGF-β1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model. Exp Mol Med 2017; 49(9): e379. doi: 10.1038/emm.2017.136 PMID: 28935976
  27. Rutges JPHJ, Kummer JA, Oner FC, et al. Increased MMP-2 activity during intervertebral disc degeneration is correlated to MMP-14 levels. J Pathol 2008; 214(4): 523-30. doi: 10.1002/path.2317 PMID: 18200629
  28. Liu S, Yang SD, Huo XW, Yang DL, Ma L, Ding WY. 17β-Estradiol inhibits intervertebral disc degeneration by down-regulating MMP-3 and MMP-13 and up-regulating type II collagen in a rat model. Artif Cells Nanomed Biotechnol 2018; 46(S2): 182-91.
  29. Trefilova VV, Shnayder NA, Petrova MM, et al. The role of polymorphisms in collagen-encoding genes in intervertebral disc degeneration. Biomolecules 2021; 11(9): 1279. doi: 10.3390/biom11091279 PMID: 34572492
  30. Mayer JE, Iatridis JC, Chan D, Qureshi SA, Gottesman O, Hecht AC. Genetic polymorphisms associated with intervertebral disc degeneration. Spine J 2013; 13(3): 299-317. doi: 10.1016/j.spinee.2013.01.041 PMID: 23537453
  31. Pfirrmann CWA, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine 2001; 26(17): 1873-8. doi: 10.1097/00007632-200109010-00011 PMID: 11568697
  32. Griffith JF, Wang YXJ, Antonio GE, et al. Modified Pfirrmann grading system for lumbar intervertebral disc degeneration. Spine 2007; 32(24): E708-12. doi: 10.1097/BRS.0b013e31815a59a0 PMID: 18007231
  33. Che YJ, Guo JB, Liang T, et al. Assessment of changes in the micro-nano environment of intervertebral disc degeneration based on Pfirrmann grade. Spine J 2019; 19(7): 1242-53. doi: 10.1016/j.spinee.2019.01.008 PMID: 30710732
  34. Quan M, Hong MW, Ko MS, Kim YY. Relationships between disc degeneration and autophagy expression in human nucleus pulposus. Orthop Surg 2020; 12(1): 312-20. doi: 10.1111/os.12573 PMID: 31802633
  35. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: Assessment of changes in vertebral body marrow with MR imaging. Radiology 1988; 166(1): 193-9. doi: 10.1148/radiology.166.1.3336678 PMID: 3336678
  36. Crockett MT, Kelly BS, van Baarsel S, Kavanagh EC. Modic type 1 vertebral endplate changes: Injury, inflammation, or infection? AJR Am J Roentgenol 2017; 209(1): 167-70. doi: 10.2214/AJR.16.17403 PMID: 28402132
  37. Yazici A, Yerlikaya T, Oniz A. An evaluation of the efficacy of a four-grade fat infiltration classification method, presented for the first time in literature. BMC Musculoskelet Disord 2022; 23(1): 226. doi: 10.1186/s12891-022-05180-5 PMID: 35260112
  38. Slabaugh MA, Friel NA, Karas V, Romeo AA, Verma NN, Cole BJ. Interobserver and intraobserver reliability of the Goutallier classification using magnetic resonance imaging: Proposal of a simplified classification system to increase reliability. Am J Sports Med 2012; 40(8): 1728-34. doi: 10.1177/0363546512452714 PMID: 22753846
  39. Fardon DF, Williams AL, Dohring EJ, Murtagh FR, Gabriel RSL, Sze GK. Lumbar disc nomenclature: Version 2.0. Spine J 2014; 14(11): 2525-45. doi: 10.1016/j.spinee.2014.04.022 PMID: 24768732
  40. Peng B, Wu W, Hou S, Li P, Zhang C, Yang Y. The pathogenesis of discogenic low back pain. J Bone Joint Surg Br 2005; 87-B(1): 62-7. doi: 10.1302/0301-620X.87B1.15708 PMID: 15686239
  41. Hayes AJ, Ralphs JR. The response of foetal annulus fibrosus cells to growth factors: Modulation of matrix synthesis by TGF-β1 and IGF-1. Histochem Cell Biol 2011; 136(2): 163-75. doi: 10.1007/s00418-011-0835-x PMID: 21739215
  42. Lee KI, Moon SH, Kim H, et al. Tissue engineering of the intervertebral disc with cultured nucleus pulposus cells using atelocollagen scaffold and growth factors. Spine 2012; 37(6): 452-8. doi: 10.1097/BRS.0b013e31823c8603 PMID: 22037529
  43. Wu PH, Kim HS, Jang IT. Intervertebral disc diseases PART 2: A review of the current diagnostic and treatment strategies for intervertebral disc disease. Int J Mol Sci 2020; 21(6): 2135. doi: 10.3390/ijms21062135 PMID: 32244936
  44. Kim HS, Wu PH, Jang IT. Lumbar degenerative disease part 1: Anatomy and pathophysiology of intervertebral discogenic pain and radiofrequency ablation of basivertebral and sinuvertebral nerve treatment for chronic discogenic back pain: A prospective case series and review of literature. Int J Mol Sci 2020; 21(4): 1483. doi: 10.3390/ijms21041483 PMID: 32098249
  45. Huang YC, Leung VYL, Lu WW, Luk KDK. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc. Spine J 2013; 13(3): 352-62. doi: 10.1016/j.spinee.2012.12.005 PMID: 23340343
  46. Du Y, Wang Z, Wu Y, Liu C, Zhang L. Intervertebral disc stem/progenitor cells: A promising "seed" for intervertebral disc regeneration. Stem Cells Int 2021; 2021: 2130727. doi: 10.1155/2021/2130727 PMID: 34367292
  47. Ryan AE, Lohan P, O’Flynn L, et al. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation. Mol Ther 2014; 22(3): 655-67. doi: 10.1038/mt.2013.261 PMID: 24184966
  48. Preda MB, Neculachi CA, Fenyo IM, et al. Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice. Cell Death Dis 2021; 12(6): 566. doi: 10.1038/s41419-021-03839-w PMID: 34075029
  49. Croft AS, Illien-Jünger S, Grad S, Guerrero J, Wangler S, Gantenbein B. The application of mesenchymal stromal cells and their homing capabilities to regenerate the intervertebral disc. Int J Mol Sci 2021; 22(7): 3519. doi: 10.3390/ijms22073519 PMID: 33805356
  50. Illien-Jünger S, Pattappa G, Peroglio M, et al. Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system. Spine 2012; 37(22): 1865-73. doi: 10.1097/BRS.0b013e3182544a8a PMID: 22433498
  51. Zhang C, Gullbrand SE, Schaer TP, et al. Combined hydrogel and mesenchymal stem cell therapy for moderate-severity disc degeneration in goats. Tissue Eng Part A 2021; 27(1-2): 117-28. doi: 10.1089/ten.tea.2020.0103 PMID: 32546053
  52. Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 1983; 97(2): 329-39. doi: 10.1083/jcb.97.2.329 PMID: 6309857
  53. Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: A review. Stem Cell Res Ther 2021; 12(1): 71. doi: 10.1186/s13287-021-02138-7 PMID: 33468232
  54. Yaghoubi Y, Movassaghpour A, Zamani M, Talebi M, Mehdizadeh A, Yousefi M. Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sci 2019; 233: 116733. doi: 10.1016/j.lfs.2019.116733 PMID: 31394127
  55. Zhou X, Cao H, Guo J, Yuan Y, Ni G. Effects of BMSC-Derived EVs on bone metabolism. Pharmaceutics 2022; 14(5): 1012. doi: 10.3390/pharmaceutics14051012 PMID: 35631601
  56. Wang Z, He Z, Liang S, Yang Q, Cheng P, Chen A. Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells. Stem Cell Res Ther 2020; 11(1): 511. doi: 10.1186/s13287-020-02032-8 PMID: 33246507
  57. Gusachenko ON, Zenkova MA, Vlassov VV. Nucleic acids in exosomes: Disease markers and intercellular communication molecules. Biochemistry 2013; 78(1): 1-7. doi: 10.1134/S000629791301001X PMID: 23379554
  58. Baglio SR, Rooijers K, Koppers-Lalic D, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 2015; 6(1): 127. doi: 10.1186/s13287-015-0116-z PMID: 26129847
  59. Yan Y, Chang C, Su J, Venø MT, Kjems J. Osteoblastogenesis alters small RNA profiles in EVs Derived from Bone Marrow Stem Cells (BMSCs) and Adipose Stem Cells (ASCs). Biomedicines 2020; 8(10): 387. doi: 10.3390/biomedicines8100387 PMID: 32998458
  60. Hassanzadeh A, Rahman HS, Markov A, et al. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther 2021; 12(1): 297. doi: 10.1186/s13287-021-02378-7 PMID: 34020704
  61. Li M, Li R, Yang S, et al. Exosomes derived from bone marrow mesenchymal stem cells prevent acidic ph-induced damage in human nucleus pulposus cells. Med Sci Monit 2020; 26: e922928. doi: 10.12659/MSM.922928 PMID: 32436493
  62. Hu Y, Tao R, Wang L, et al. Exosomes derived from bone mesenchymal stem cells alleviate compression-induced nucleus pulposus cell apoptosis by inhibiting oxidative stress. Oxid Med Cell Longev 2021; 2021: 2310025. doi: 10.1155/2021/2310025 PMID: 34733401
  63. Zhang Z, Zhang L, Yang J, et al. Influence of extracellular nanovesicles derived from adipose-derived stem cells on nucleus pulposus cell from patients with intervertebral disc degeneration. Exp Ther Med 2021; 22(6): 1431. doi: 10.3892/etm.2021.10866 PMID: 34707712
  64. Kozacı LD, Guner A, Oktay G, Guner G. Alterations in biochemical components of extracellular matrix in intervertebral disc herniation: Role of MMP-2 and TIMP-2 in type II collagen loss. Cell Biochem Funct 2006; 24(5): 431-6. doi: 10.1002/cbf.1250 PMID: 16142692
  65. Xing H, Zhang Z, Mao Q, et al. Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration. J Nanobiotechnol 2021; 19(1): 264. doi: 10.1186/s12951-021-00991-5 PMID: 34488795
  66. Lyu FJ, Cui H, Pan H, et al. Painful intervertebral disc degeneration and inflammation: From laboratory evidence to clinical interventions. Bone Res 2021; 9(1): 7. doi: 10.1038/s41413-020-00125-x PMID: 33514693
  67. Xia C, Zeng Z, Fang B, et al. Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects. Free Radic Biol Med 2019; 143: 1-15. doi: 10.1016/j.freeradbiomed.2019.07.026 PMID: 31351174
  68. Zhang L, Wang Q, Su H, Cheng J. Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts. J Biosci Bioeng 2021; 131(6): 671-8. doi: 10.1016/j.jbiosc.2021.02.007 PMID: 33849774
  69. Feng C, Yang M, Lan M, et al. ROS: Crucial intermediators in the pathogenesis of intervertebral disc degeneration. Oxid Med Cell Longev 2017; 2017: 5601593. doi: 10.1155/2017/5601593 PMID: 28392887
  70. Hingert D, Ekström K, Aldridge J, Crescitelli R, Brisby H. Extracellular vesicles from human mesenchymal stem cells expedite chondrogenesis in 3D human degenerative disc cell cultures. Stem Cell Res Ther 2020; 11(1): 323. doi: 10.1186/s13287-020-01832-2 PMID: 32727623
  71. Xie L, Chen Z, Liu M, et al. MSC-derived exosomes protect vertebral endplate chondrocytes against apoptosis and calcification via the miR-31-5p/ATF6 axis. Mol Ther Nucleic Acids 2020; 22: 601-14. doi: 10.1016/j.omtn.2020.09.026 PMID: 33230460
  72. Gong C, Zhang H. Autophagy as a potential therapeutic target in intervertebral disc degeneration. Life Sci 2021; 273: 119266. doi: 10.1016/j.lfs.2021.119266 PMID: 33631177
  73. Li Z, Kong L, Liu C, Xu HG. Human bone marrow mesenchymal stem cell-derived exosomes attenuate IL-1β-induced annulus fibrosus cell damage. Am J Med Sci 2020; 360(6): 693-700. doi: 10.1016/j.amjms.2020.07.025 PMID: 32771218
  74. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell 2009; 136(4): 731-45. doi: 10.1016/j.cell.2009.01.042 PMID: 19239892
  75. Yue B, Yang H, Wang J, et al. Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis. Cell Prolif 2020; 53(7): e12857. doi: 10.1111/cpr.12857 PMID: 32578911
  76. Yun Z, Wang Y, Feng W, Zang J, Zhang D, Gao Y. Overexpression of microRNA-185 alleviates intervertebral disc degeneration through inactivation of the Wnt/β-catenin signaling pathway and downregulation of Galectin-3. Mol Pain 2020; 16: 1-13. doi: 10.1177/1744806920902559 PMID: 32090685
  77. Yang Q, Guo XP, Cheng YL, Wang Y. MicroRNA-143-5p targeting eEF2 gene mediates intervertebral disc degeneration through the AMPK signaling pathway. Arthritis Res Ther 2019; 21(1): 97. doi: 10.1186/s13075-019-1863-5 PMID: 30987676
  78. Zhao K, Zhang Y, Kang L, et al. Epigenetic silencing of miRNA-143 regulates apoptosis by targeting BCL2 in human intervertebral disc degeneration. Gene 2017; 628: 259-66. doi: 10.1016/j.gene.2017.07.043 PMID: 28716711
  79. Kang L, Yang C, Song Y, et al. MicroRNA-494 promotes apoptosis and extracellular matrix degradation in degenerative human nucleus pulposus cells. Oncotarget 2017; 8(17): 27868-81. doi: 10.18632/oncotarget.15838 PMID: 28427186
  80. Zhang HJ, Ma XH, Xie SL, Qin S, Liu CZ, Zhang ZG. Knockdown of miR-660 protects nucleus pulposus cells from TNF-a-induced apoptosis by targeting serum amyloid A1. J Orthop Surg Res 2020; 15(1): 7. doi: 10.1186/s13018-019-1538-6 PMID: 31907065
  81. Zhou J, Sun J, Markova DZ, et al. MicroRNA-145 overexpression attenuates apoptosis and increases matrix synthesis in nucleus pulposus cells. Life Sci 2019; 221: 274-83. doi: 10.1016/j.lfs.2019.02.041 PMID: 30797016
  82. Chen H, Wang J, Hu B, et al. MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2. Mol Cell Biochem 2015; 406(1-2): 21-30. doi: 10.1007/s11010-015-2420-4 PMID: 25910896
  83. Dong W, Liu J, Lv Y, et al. miR‐640 aggravates intervertebral disc degeneration via NF‐κB and WNT signalling pathway. Cell Prolif 2019; 52(5): e12664. doi: 10.1111/cpr.12664 PMID: 31343104
  84. Kong L, Sun M, Jiang Z, Li L, Lu B. MicroRNA-194 inhibits lipopolysaccharide-induced inflammatory response in nucleus pulposus cells of the intervertebral disc by targeting TNF receptor-associated factor 6 (TRAF6). Med Sci Monit 2018; 24: 3056-67. doi: 10.12659/MSM.907280 PMID: 29745371
  85. Li H, Cui Q, Dong Z, Zhang J, Li H, Zhao L. Downregulation of miR-27b is involved in loss of type II collagen by directly targeting matrix metalloproteinase 13 (MMP13) in human intervertebral disc degeneration. Spine 2016; 41(3): E116-23. doi: 10.1097/BRS.0000000000001139 PMID: 26583473
  86. Xu Y, Zhang Z, Zheng Y, Feng S. Dysregulated miR-133a mediates loss of type II collagen by directly targeting matrix metalloproteinase 9 (MMP9) in human intervertebral disc degeneration. Spine 2016; 41(12): E717-24. doi: 10.1097/BRS.0000000000001375 PMID: 26656045
  87. Wang C, Zhang ZZ, Yang W, et al. MiR-210 facilitates ECM degradation by suppressing autophagy via silencing of ATG7 in human degenerated NP cells. Biomed Pharmacother 2017; 93: 470-9. doi: 10.1016/j.biopha.2017.06.048 PMID: 28667916
  88. Liu J, Yu J, Jiang W, He M, Zhao J. Targeting of CDKN 1B by miR-222-3p may contribute to the development of intervertebral disc degeneration. FEBS Open Bio 2019; 9(4): 728-35. doi: 10.1002/2211-5463.12609 PMID: 30984546
  89. Wang J, Liu X, Sun B, Du W, Zheng Y, Sun Y. Upregulated miR-154 promotes ECM degradation in intervertebral disc degeneration. J Cell Biochem 2019; 120(7): 11900-7. doi: 10.1002/jcb.28471 PMID: 30825225
  90. Liu W, Xia P, Feng J, et al. MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration. Exp Cell Res 2017; 359(1): 39-49. doi: 10.1016/j.yexcr.2017.08.011 PMID: 28793234
  91. Liu W, Zhang Y, Xia P, et al. MicroRNA-7 regulates IL-1β-induced extracellular matrix degeneration by targeting GDF5 in human nucleus pulposus cells. Biomed Pharmacother 2016; 83: 1414-21. doi: 10.1016/j.biopha.2016.08.062 PMID: 27583982
  92. Zhang WL, Chen YF, Meng HZ, et al. Role of miR-155 in the regulation of MMP-16 expression in intervertebral disc degeneration. J Orthop Res 2017; 35(6): 1323-34. doi: 10.1002/jor.23313 PMID: 27227700
  93. Chen Z, Han Y, Deng C, et al. Inflammation‐dependent downregulation of miR‐194‐5p contributes to human intervertebral disc degeneration by targeting CUL4A and CUL4B. J Cell Physiol 2019; 234(11): 19977-89. doi: 10.1002/jcp.28595 PMID: 30945295
  94. Hai B, Ma Y, Pan X, et al. Melatonin benefits to the growth of human annulus fibrosus cells through inhibiting miR-106a-5p/ATG7 signaling pathway. Clin Interv Aging 2019; 14: 621-30. doi: 10.2147/CIA.S193765 PMID: 30992660
  95. Zhu L, Shi Y, Liu L, Wang H, Shen P, Yang H. Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: Therapeutic potential for intervertebral disc degenerative diseases. Cell Cycle 2020; 19(14): 1727-39. doi: 10.1080/15384101.2020.1769301 PMID: 32635856
  96. Zhu G, Yang X, Peng C, Yu L, Hao Y. Exosomal miR-532-5p from bone marrow mesenchymal stem cells reduce intervertebral disc degeneration by targeting RASSF5. Exp Cell Res 2020; 393(2): 112109. doi: 10.1016/j.yexcr.2020.112109 PMID: 32464126
  97. Cheng X, Zhang G, Zhang L, et al. Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med 2018; 22(1): 261-76. doi: 10.1111/jcmm.13316 PMID: 28805297
  98. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9(6): 654-9. doi: 10.1038/ncb1596 PMID: 17486113
  99. Ridder K, Keller S, Dams M, et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol 2014; 12(6): e1001874. doi: 10.1371/journal.pbio.1001874 PMID: 24893313
  100. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495(7441): 333-8. doi: 10.1038/nature11928 PMID: 23446348
  101. Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis. Cell Res 2015; 25(8): 981-4. doi: 10.1038/cr.2015.82 PMID: 26138677
  102. Forsberg MH, Kink JA, Hematti P, Capitini CM. Mesenchymal stromal cells and exosomes: Progress and challenges. Front Cell Dev Biol 2020; 8: 665. doi: 10.3389/fcell.2020.00665 PMID: 32766255
  103. Gowen A, Shahjin F, Chand S, Odegaard KE, Yelamanchili SV. Mesenchymal stem cell-derived extracellular vesicles: Challenges in clinical applications. Front Cell Dev Biol 2020; 8: 149. doi: 10.3389/fcell.2020.00149 PMID: 32226787
  104. Zhang Q, Shen Y, Zhao S, Jiang Y, Zhou D, Zhang Y. Exosomes miR-15a promotes nucleus pulposus-mesenchymal stem cells chondrogenic differentiation by targeting MMP-3. Cell Signal 2021; 86: 110083. doi: 10.1016/j.cellsig.2021.110083 PMID: 34252537
  105. Yuan Q, Wang X, Liu L, et al. Exosomes derived from human placental mesenchymal stromal cells carrying antagomiR-4450 alleviate intervertebral disc degeneration through upregulation of ZNF121. Stem Cells Dev 2020; 29(16): 1038-58. doi: 10.1089/scd.2020.0083 PMID: 32620067
  106. Zhang J, Zhang J, Zhang Y, et al. Mesenchymal stem cells-derived exosomes ameliorate intervertebral disc degeneration through inhibiting pyroptosis. J Cell Mol Med 2020; 24(20): 11742-54. doi: 10.1111/jcmm.15784 PMID: 32860495
  107. Yuan X, Li T, Shi L, Miao J, Guo Y, Chen Y. Human umbilical cord mesenchymal stem cells deliver exogenous miR-26a-5p via exosomes to inhibit nucleus pulposus cell pyroptosis through METTL14/NLRP3. Mol Med 2021; 27(1): 91. doi: 10.1186/s10020-021-00355-7 PMID: 34412584

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers